Liu Dongdong, Huang Shaopeng, Yuan Yue, Liu Jinfeng
Department of Painology, The Second Affiliated Hospital of Harbin Medical University, No 246 Xuefu Road, Nangang District, Harbin, 150086, China.
The Second Hospital of Harbin, No 38 Weixing Road, Daowai District, Harbin, China.
Mol Neurobiol. 2025 May 29. doi: 10.1007/s12035-025-04999-y.
Neuropathic pain (NP) is a chronic disease due to nerve injury, viral infections, etc. Inflammatory factors are a key part of its pathological mechanism, and NLRP3 has been widely studied in other diseases; however, its study in NP is still scarce. We analyzed genes differentially expressed in NP and normal samples using public databases. Six key markers were screened by WGCNA and a machine learning approach. The research value of key markers in NP was further verified by correlation analysis, expression analysis and validation, regulatory network construction, and molecular docking. Our results identified six reliable key markers: Lyz2, Fcgr4, Gm2a, Sumf1, Zbtb7a, and Treml2. After correlation analysis and molecular functional similarity analysis, it was concluded that Lyz2 might be a key marker of NLRP3 with greater potential in NP. Our study may find new targets for NP.
神经性疼痛(NP)是一种由神经损伤、病毒感染等引起的慢性疾病。炎症因子是其病理机制的关键部分,NLRP3在其他疾病中已得到广泛研究;然而,其在NP中的研究仍然很少。我们使用公共数据库分析了NP样本和正常样本中差异表达的基因。通过加权基因共表达网络分析(WGCNA)和机器学习方法筛选出六个关键标志物。通过相关性分析、表达分析与验证、调控网络构建以及分子对接,进一步验证了关键标志物在NP中的研究价值。我们的结果确定了六个可靠的关键标志物:Lyz2、Fcgr4、Gm2a、Sumf1、Zbtb7a和Treml2。经过相关性分析和分子功能相似性分析,得出结论:Lyz2可能是NLRP3在NP中具有更大潜力的关键标志物。我们的研究可能为NP找到新的靶点。